Inflammatix Appoints Heiner Dreismann as New Board Member

BURLINGAME, Calif., July 10, 2023 /PRNewswire/ — Inflammatix, a pioneering molecular diagnostics company, announced today the appointment of Heiner Dreismann, PhD, as a member of the company’s board of directors. Inflammatix appoints former Roche Molecular Systems CEO Heiner Dreismann,…

Click here to view original post